search icon
  • Find Practice Guidelines

    Find Practice Guidelines

    Also available:

The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

  • Policy News


    STAAR Act

    The STAAR Act was reintroduced by Sen. Sherrod Brown this week. The bill, championed by IDSA, provides stronger federal leadership to coordinate activities that address resistance and strengthen accountability.

  • Breaking News and Alerts

    4/22/2014 4:16:51 PM

    IDSA Continues to Recommend Antivirals for Influenza

    IDSA continues to recommend the use of neuraminidase inhibitor antiviral drugs in the treatment of influenza.

    4/22/2014 1:56:41 PM

    CUBICIN (daptomycin for injection) by Cubist Pharmaceuticals: Recall - Presence of Particulate Matter

    Cubist is voluntarily recalling one lot of daptomycin for injection due to the presence of particulate matter, identified as glass particles.  

    4/15/2014 9:52:13 AM

    CDC Continues to Recommend Influenza Antiviral Medications

    CDC continues to recommend the use of the neuraminidase inhibitor antiviral drugs as an important adjunct to influenza vaccination in the treatment of influenza.

    4/9/2014 11:44:07 AM

    HIV/AIDS Update - Changes to the Prezista (darunavir) label

    FDA Alert

  • News from IDSA and the Journals

    Stroke Risk Higher After Shingles, But Antivirals May Help

    >> Read more

    A new study in Clinical Infectious Diseases finds increased risk of stroke following shingles but suggests antiviral drugs may offer some protection.

| HIVMA | Contact Us

© Copyright IDSA 2013 Infectious Diseases Society of America

Full Site Mobile Site